Funding Opportunities

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed)

RFA-CA-19-020
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed)

RFA-CA-19-019
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)

RFA-CA-19-028
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trials Optional)

RFA-CA-19-027
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trials Optional)

RFA-CA-19-026
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)

RFA-CA-19-025
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U01 Clinical Trials Optional)

RFA-CA-19-024
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trials Optional)

RFA-CA-19-023
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019

Notice of a Joint Veterans Health Administration/National Cancer Institute Data Science Initiative called the Big Data Scientist Training Enhancement Program (BD-STEP)

NOT-CA-19-034
Application Receipt Date: July 19, 2019

Revision Applications to National Cancer Institute (NCI) supported U01 Awards to Include Research on the NCIs Provocative Questions (U01 Clinical Trial Optional)

RFA-CA-18-022
Application Receipt Date: June 29, 2018, October 30, 2018

Revision Applications to National Cancer Institute (NCI)-supported P01 Awards to Include Research on the NCIs Provocative Questions (P01 Clinical Trial Optional)

RFA-CA-18-023
Application Receipt Date: June 29, 2018, October 30, 2018

Revision Applications to National Cancer Institute (NCI)-supported P50 Awards to Include Research on the NCIs Provocative Questions (P50 Clinical Trial Optional)

RFA-CA-18-024
Application Receipt Date: June 29, 2018, October 30, 2018

Revision Applications to NCI-supported R01 Awards to Include Research on the NCI's Provocative Questions (R01)

RFA-CA-17-019
Application Receipt Date: June 28, 2017, October 30, 2017, June 28, 2018, October 30, 2018

Revision Applications to National Cancer Institute (NCI)-supported U01 Awards to Include Research on the NCI's Provocative Questions (U01)

RFA-CA-17-020
Application Receipt Date: June 28, 2017, October 30, 2017, June 28, 2018, October 30, 2018

Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional)

RFA-CA-18-019
Application Receipt Date: June 29, 2018, October 30, 2018

Revision Applications to National Cancer Institute (NCI)-supported P01 Awards to Include Research on the NCI's Provocative Questions (P01)

RFA-CA-17-021
Application Receipt Date: June 28, 2017, October 30, 2017, June 28, 2018, October 30, 2018

Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional)

RFA-CA-18-020
Application Receipt Date: June 29, 2018, October 30, 2018

Revision Applications to National Cancer Institute (NCI)-supported P50 Awards to Include Research on the NCI's Provocative Questions (P50)

RFA-CA-17-022
Application Receipt Date: June 28, 2017, October 30, 2017, June 28, 2018, October 30, 2018